NASDAQ:AEHA Aesther Healthcare Acquisition (AEHA) Stock Price, News & Analysis → The only AI company you should be looking at (From Behind the Markets) (Ad) Free AEHA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$8.55▼$10.8050-Day Range$8.93▼$13.0052-Week Range$8.20▼$14.22Volume1.29 million shsAverage Volume434,237 shsMarket Capitalization$131.77 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Aesther Healthcare Acquisition alerts: Email Address Ad Colonial MetalsThe asset beating inflation by 4x"Trump Loophole" Beats Inflation? Inflation has been out of control for years. Forcing you to work longer and harder for more money that is worth less. By using the "Trump Loophole", you can use a special retirement account to buy gold — and other precious metals — without taxes or penalties.That's why we have released our Free Precious Metals Investment Guide that explains all the details About Aesther Healthcare Acquisition Stock (NASDAQ:AEHA)Aesther Healthcare Acquisition Corp. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses primarily in the pharmaceutical and medical devices sectors. The company was incorporated in 2021 and is based in New York, New York.Read More Ad Colonial MetalsThe asset beating inflation by 4x"Trump Loophole" Beats Inflation? Inflation has been out of control for years. Forcing you to work longer and harder for more money that is worth less. By using the "Trump Loophole", you can use a special retirement account to buy gold — and other precious metals — without taxes or penalties.That's why we have released our Free Precious Metals Investment Guide that explains all the details AEHA Stock News HeadlinesJune 12, 2023 | thestreet.comKPMG Buys Beacon Partners, Bolsters Health Care Consulting BusinessJune 6, 2023 | wsj.comHealthcare AI Acquisition Corp. Cl AMay 5, 2024 | Behind the Markets (Ad)The only AI company you should be looking atThis is the ONLY AI company you should be watching right now. No. It's not Nvidia, Intel, or Microsoft... It's a tiny biotech using proprietary AI to assist in new drug discovery at a rate 100,000 times faster than a human. This new drug discovery technique will change the market. And that's why they received a $50 million investment from an AI powerhouse.May 23, 2023 | morningstar.comHealthcare AI Acquisition Corp Units (1 Ord Share Class A & 1/2 War) HAIAU Stock QuoteMay 15, 2023 | finance.yahoo.comEuropean Healthcare Acquisition & Growth Company B.V. (AMS:EHCS) most popular amongst retail investors who own 57%, insiders hold 33%February 15, 2023 | finanznachrichten.deAesther Healthcare Acquisition Corp.: Ocean Biomedical Provides Corporate Update and Company SummaryFebruary 15, 2023 | finance.yahoo.comOcean Biomedical Debuts as Publicly Traded CompanyFebruary 9, 2023 | finance.yahoo.comOcean Biomedical and Aesther Healthcare Acquisition Corp. Announce the Award of New Patents for Novel Monospecific and Bispecific Antibodies that Suppress Multiple Cancer TypesMay 5, 2024 | Behind the Markets (Ad)The only AI company you should be looking atThis is the ONLY AI company you should be watching right now. No. It's not Nvidia, Intel, or Microsoft... It's a tiny biotech using proprietary AI to assist in new drug discovery at a rate 100,000 times faster than a human. This new drug discovery technique will change the market. And that's why they received a $50 million investment from an AI powerhouse.February 2, 2023 | finance.yahoo.comOcean Biomedical Chairman Chirinjeev Kathuria on Going Public Via SPACFebruary 1, 2023 | bizjournals.comOcean Biomedical SPAC deal set for shareholder voteFebruary 1, 2023 | finance.yahoo.comAesther Healthcare Acquisition Corp (NASDAQ: AEHA) Announces Measures regarding Excise TaxJanuary 31, 2023 | finance.yahoo.comOcean Biomedical Chairman Kathuria on Going Public Via SPACJanuary 30, 2023 | finance.yahoo.comOcean Biomedical and Aesther Healthcare Acquisition Corp. Announce Publication of Discovery Data for a Major Anti-Tumor Pathway in Malignant Melanoma and Other CancersJanuary 24, 2023 | finance.yahoo.comOcean Biomedical Provides Corporate Update and Company SummaryJanuary 13, 2023 | finance.yahoo.comAesther Healthcare Acquisition Corp (NASDAQ: AEHA) Announces Filing of Definitive Proxy Statement with SEC in Connection with its Proposed Business Combination with Ocean Biomedical, Inc.November 1, 2022 | finance.yahoo.comNovel Malaria Drug Discovery Presented at the ASTMH Tropical Medicine Meeting by Ocean Biomedical’s Scientific Co-founder, Dr. Jake Kurtis, unveiling the potential for a new class of Antimalarial Drugs.October 5, 2022 | finance.yahoo.comAesther Healthcare Acquisition Corp (NASDAQ: AEHA) and Ocean Biomedical, Inc. Announce Execution of a Second up to $40 Million Backstop Agreement, for a Total of up to $80 MillionSeptember 22, 2022 | finance.yahoo.comBuilding on Their Innovative mRNA Vaccine Program, Ocean Biomedical, Inc. and Aesther Healthcare Acquisition Corp. (NASDAQ: AEHA) Recently Announced Business Combination to Support the Discovery of a New Class of Antimalarial Drugs.September 19, 2022 | finance.yahoo.comAesther Healthcare Acquisition Corp (NASDAQ: AEHA) Announces Filing of Preliminary Proxy Statement with SEC in Connection with its Proposed Business Combination with Ocean Biomedical, Inc.September 8, 2022 | finance.yahoo.comAesther Healthcare Acquisition Corp (NASDAQ: AEHA) and Ocean Biomedical, Inc. Announce $75 Million Common Stock Purchase Transaction with White Lion CapitalSeptember 6, 2022 | uk.finance.yahoo.comAesther Healthcare Acquisition Corp. (AEHA)September 6, 2022 | uk.finance.yahoo.comAesther Healthcare Acquisition Corp. (AEHA)September 6, 2022 | finance.yahoo.comDiscovery of Bispecific Antibodies and Immune Checkpoint Inhibitors Which Kill Glioblastoma and Block the Metastasis of Malignant Melanoma Cells to the Lung By Over 90% Announced by Ocean Biomedical and Aesther Healthcare (NASDAQ: AEHA)September 6, 2022 | finance.yahoo.comDiscovery of Bispecific Antibodies and Immune Checkpoint Inhibitors That Kill Glioblastoma Cells and Melanoma Cells, and Block the Metastasis of Malignant Melanoma Cells to the Lung by Over 90%, Announced by Ocean Biomedical, Inc. and Aesther Healthcare Acquisition Corp. (NASDAQ: AEHA)September 1, 2022 | seekingalpha.comOcean Biomedical agrees to go public through deal with SPAC Aesther HealthcareAugust 31, 2022 | finance.yahoo.comAesther Healthcare Acquisition Corp. Has Entered Into an Agreement and Plan of Merger with Ocean Biomedical, Inc., a Next-Generation Biopharma Company, to List on NASDAQSee More Headlines Receive AEHA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aesther Healthcare Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/05/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:AEHA CUSIPN/A CIK1869974 WebN/A Phone646-908-2658FaxN/AEmployees2,021Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio0.29 Quick Ratio0.29 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.14) per share Price / Book-71.14Miscellaneous Outstanding Shares13,230,000Free Float10,606,000Market Cap$131.77 million OptionableNot Optionable Beta0.04 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesMr. Surendra K. Ajjarapu (Age 51)CEO & Chairman Mr. Howard A. Doss (Age 68)CFO & Sec. Key CompetitorsSagimet BiosciencesNASDAQ:SGMTPDS BiotechnologyNASDAQ:PDSBInterCureNASDAQ:INCRAEON BiopharmaNASDAQ:AEONVistagen TherapeuticsNASDAQ:VTGNView All Competitors This page (NASDAQ:AEHA) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCThe asset beating inflation by 4xColonial MetalsCould Your Accounts Be Frozen?Allegiance GoldThe only AI company you should be looking atBehind the MarketsHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aesther Healthcare Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
